Biomarker Type: Proteomic
-
Robust Identification of molecular phenotypes using semi-supervised learning
-
An independent validation of a screening test using mass spectrometry for detection of hepatocellular carcinoma
-
Set Enrichment Analysis: An Approach for Relating MALDI MS Features to Biological Processes
-
Intellectual property—The Foundation of Innovation: A scientist’s guide to intellectual property
-
Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
-
Real-World Performance of Blood-Based Proteomic Profiling in Immunotherapy Treatment in Advanced Stage NSCLC
-
Evaluation of immune-related markers in the circulating proteome and their association with atezolizumab efficacy in patients with 2L+ NSCLC
-
Early diagnosis of pulmonary nodules: biomarker performance in cancer subtypes found in the PANOPTIC study
-
Early diagnosis of pulmonary nodules: biomarker performance in patients with solitary or multiple nodules in the PANOPTIC study
-
Early diagnosis pulmonary nodules: cancer diagnosis timing during CT surveillance in the PANOPTIC study